Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium

Imagem de Miniatura
Arquivos
art_ELUF-NETO_Diet_and_the_risk_of_head_and_neck_2012.PDF (452.18 KB)
Citações na Scopus
116
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
CHUANG, Shu-Chun
JENAB, Mazda
HECK, Julia E.
BOSETTI, Cristina
TALAMINI, Renato
MATSUO, Keitaro
CASTELLSAGUE, Xavier
FRANCESCHI, Silvia
HERRERO, Rolando
WINN, Deborah M.
Citação
CANCER CAUSES & CONTROL, v.23, n.1, p.69-88, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
We investigated the association between diet and head and neck cancer (HNC) risk using data from the International Head and Neck Cancer Epidemiology (INHANCE) consortium. The INHANCE pooled data included 22 case-control studies with 14,520 cases and 22,737 controls. Center-specific quartiles among the controls were used for food groups, and frequencies per week were used for single food items. A dietary pattern score combining high fruit and vegetable intake and low red meat intake was created. Odds ratios (OR) and 95% confidence intervals (CI) for the dietary items on the risk of HNC were estimated with a two-stage random-effects logistic regression model. An inverse association was observed for higher-frequency intake of fruit (4th vs. 1st quartile OR = 0.52, 95% CI = 0.43-0.62, p (trend) < 0.01) and vegetables (OR = 0.66, 95% CI = 0.49-0.90, p (trend) = 0.01). Intake of red meat (OR = 1.40, 95% CI = 1.13-1.74, p (trend) = 0.13) and processed meat (OR = 1.37, 95% CI = 1.14-1.65, p (trend) < 0.01) was positively associated with HNC risk. Higher dietary pattern scores, reflecting high fruit/vegetable and low red meat intake, were associated with reduced HNC risk (per score increment OR = 0.90, 95% CI = 0.84-0.97).
Palavras-chave
Diet, Head and neck cancer, Fruit and vegetable, Red meat, Processed meat
URI
https://observatorio.fm.usp.br/handle/OPI/712
Referências
  1. Anantharaman D, 2007, CARCINOGENESIS, V28, P1455, DOI 10.1093/carcin/bgm038
  2. Aune D, 2009, ASIAN PAC J CANCER P, V10, P429
  3. Aune D, 2009, ASIAN PAC J CANCER P, V10, P869
  4. BLOT WJ, 1988, CANCER RES, V48, P3282
  5. Boeing H, 2006, CANCER CAUSE CONTROL, V17, P957, DOI 10.1007/s10552-006-0036-4
  6. Bosetti C, 2002, INT J CANCER, V100, P355, DOI 10.1002/ijc.10485
  7. Bosetti C, 2002, BRIT J CANCER, V87, P1230, DOI 10.1038/sj.bjc.6606639
  8. Bouvard V, 2009, LANCET ONCOL, V10, P321
  9. Dahlstrom KR, 2008, HEAD NECK-J SCI SPEC, V30, P75, DOI 10.1002/hed.20664
  10. DANIEL CR, 2011, CANC PREV RES PHILA
  11. DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
  12. De Stefani E, 2005, NUTR CANCER, V51, P132, DOI 10.1207/s15327914nc5102_2
  13. De Stefani E, 1999, ORAL ONCOL, V35, P17, DOI 10.1016/S1368-8375(98)00060-8
  14. Dyer AR, 2003, J HUM HYPERTENS, V17, P641, DOI 10.1038/sj.jhh.1001607
  15. Edefonti V, 2010, ORAL ONCOL, V46, P343, DOI 10.1016/j.oraloncology.2009.11.017
  16. Edefonti V, 2010, CANCER EPIDEM BIOMAR, V19, P18, DOI 10.1158/1055-9965.EPI-09-0900
  17. Farshadpour F, 2007, ORAL DIS, V13, P239, DOI 10.1111/j.1601-0825.2006.01274.x
  18. Ferlay J SH, 2010, IARC CANCERBASE
  19. Fioretti F, 1999, ORAL ONCOL, V35, P375, DOI 10.1016/S1368-8375(98)00125-0
  20. Foschi R, 2010, CANCER CAUSE CONTROL, V21, P237, DOI 10.1007/s10552-009-9454-4
  21. FRANCESCHI S, 1991, INT J CANCER, V47, P20, DOI 10.1002/ijc.2910470105
  22. Franceschi S, 1999, BRIT J CANCER, V80, P614, DOI 10.1038/sj.bjc.6690400
  23. Freedman ND, 2008, INT J CANCER, V122, P2330, DOI 10.1002/ijc.23319
  24. Garavello W, 2007, ANN ONCOL, V18, P1104, DOI 10.1093/annonc/mdm078
  25. Garrote LF, 2001, BRIT J CANCER, V85, P46, DOI 10.1054/bjoc.2000.1825
  26. Gaudet MM, 2010, INT J EPIDEMIOL, V39, P1091, DOI 10.1093/ije/dyp380
  27. Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179
  28. Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347
  29. Haug U, 2007, CLIN CHEM, V53, P787, DOI 10.1373/clinchem.2006.078188
  30. Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
  31. Kapil Umesh, 2005, Asian Pac J Cancer Prev, V6, P202
  32. Kjaerheim K, 1998, CANCER CAUSE CONTROL, V9, P99
  33. Kreimer AR, 2006, INT J CANCER, V118, P2293, DOI 10.1002/ijc.21577
  34. Lagiou P, 2009, INT J CANCER, V124, P2671, DOI 10.1002/ijc.24246
  35. Lajer CB, 2010, APMIS, V118, P510, DOI 10.1111/j.1600-0463.2010.02624.x
  36. Lam TK, 2009, CANCER RES, V69, P932, DOI 10.1158/0008-5472.CAN-08-3162
  37. LaVecchia C, 1997, ORAL ONCOL, V33, P302, DOI 10.1016/S1368-8375(97)00029-8
  38. La Vecchia C, 1999, INT J CANCER, V82, P151, DOI 10.1002/(SICI)1097-0215(19990702)82:1<151::AID-IJC25>3.0.CO;2-9
  39. LAVECCHIA C, 1991, INT J EPIDEMIOL, V20, P39, DOI 10.1093/ije/20.1.39
  40. LAVECCHIA C, 1990, CANCER RES, V50, P4497
  41. Lee YCA, 2008, CANCER EPIDEM BIOMAR, V17, P1974, DOI 10.1158/1055-9965.EPI-08-0047
  42. Levi F, 1998, INT J CANCER, V77, P705, DOI 10.1002/(SICI)1097-0215(19980831)77:5<705::AID-IJC8>3.0.CO;2-Z
  43. Levi F, 2004, ANN ONCOL, V15, P346, DOI 10.1093/annonc/mdh060
  44. Lissowska J, 2003, EUR J CANCER PREV, V12, P25, DOI 10.1097/01.cej.0000043735.13672.78
  45. Lucenteforte E, 2009, ORAL ONCOL, V45, P461, DOI 10.1016/j.oraloncology.2008.09.002
  46. MacLean CH, 2006, JAMA-J AM MED ASSOC, V295, P403, DOI 10.1001/jama.295.4.403
  47. Meyer MS, 2008, CANCER EPIDEM BIOMAR, V17, P3419, DOI 10.1158/1055-9965.EPI-08-0560
  48. Nair U, 2001, IARC Sci Publ, V154, P271
  49. Negri E, 2009, INT J CANCER, V124, P394, DOI 10.1002/ijc.23848
  50. Northrop-Clewes CA, 2007, CLIN CHIM ACTA, V377, P14, DOI 10.1016/j.cca.2006.08.028
  51. Panda K, 2000, FREE RADICAL BIO MED, V29, P115, DOI 10.1016/S0891-5849(00)00297-5
  52. Park JH, 2003, TRANSPORT RES E-LOG, V39, P1, DOI 10.1016/S1366-5545(02)00023-6
  53. Peters ES, 2008, HEAD NECK-J SCI SPEC, V30, P1193, DOI 10.1002/hed.20846
  54. Rajkumar T, 2003, EUR J CANCER PREV, V12, P135, DOI 10.1097/01.cej.0000062796.86004.7c
  55. Ramroth H, 2004, METHOD INFORM MED, V43, P499
  56. ROGERS MAM, 1993, CANCER EPIDEM BIOMAR, V2, P305
  57. Sanchez MJ, 2003, EUR J CANCER PREV, V12, P49, DOI 10.1097/01.cej.0000043739.13672.47
  58. Sapkota A, 2008, CANCER CAUSE CONTROL, V19, P1161, DOI 10.1007/s10552-008-9183-0
  59. Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2
  60. Suzuki T, 2007, CANCER SCI, V98, P1439, DOI 10.1111/j.1349-7006.2007.00533.x
  61. Takezaki T, 1996, JPN J CANCER RES, V87, P555
  62. Tavani A, 2000, INT J CANCER, V86, P425, DOI 10.1002/(SICI)1097-0215(20000501)86:3<425::AID-IJC19>3.3.CO;2-J
  63. Tavani A, 2001, EUR J CANCER PREV, V10, P191, DOI 10.1097/00008469-200104000-00015
  64. Tzoulaki I, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a258
  65. Willett WC, 1997, AM J CLIN NUTR, V65, pS1220
  66. World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P
  67. ZHENG W, 1992, CANCER EPIDEM BIOMAR, V1, P441
  68. Zheng W, 2009, NUTR CANCER, V61, P437, DOI 10.1080/01635580802710741
  69. Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605
  70. *IARC WORK GROUP, 2007, HUM PAP, P1

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPR
Artigos e Materiais de Revistas Científicas - LIM/38